View in EDS HTML Full Text PDF Full Text

Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.
Authors: Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium., Van den Eynde A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium., Freire Boullosa L; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium., Melis J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium., Hermans C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium., Merlin C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium., Lau HW; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium., Van Audenaerde J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium., Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium., Smits E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium., Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium., Jacobs J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Argenx BV, Zwijnaarde, Belgium.
Source: Oncoimmunology [Oncoimmunology] 2023 Mar 23; Vol. 12 (1), pp. 2192100. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36970072
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Flieswasser+T%22">Flieswasser T</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+den+Eynde+A%22">Van den Eynde A</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.<br /><searchLink fieldCode="AU" term="%22Freire+Boullosa+L%22">Freire Boullosa L</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Melis+J%22">Melis J</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Hermans+C%22">Hermans C</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Merlin+C%22">Merlin C</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Lau+HW%22">Lau HW</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Audenaerde+J%22">Van Audenaerde J</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Lardon+F%22">Lardon F</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Smits+E%22">Smits E</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium.<br /><searchLink fieldCode="AU" term="%22Pauwels+P%22">Pauwels P</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.<br /><searchLink fieldCode="AU" term="%22Jacobs+J%22">Jacobs J</searchLink>; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Argenx BV, Zwijnaarde, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2023 Mar 23; Vol. 12 (1), pp. 2192100. <i>Date of Electronic Publication: </i>2023 Mar 23 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36970072
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2023.2192100
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2192100
    Titles:
      – TitleFull: Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Flieswasser T
      – PersonEntity:
          Name:
            NameFull: Van den Eynde A
      – PersonEntity:
          Name:
            NameFull: Freire Boullosa L
      – PersonEntity:
          Name:
            NameFull: Melis J
      – PersonEntity:
          Name:
            NameFull: Hermans C
      – PersonEntity:
          Name:
            NameFull: Merlin C
      – PersonEntity:
          Name:
            NameFull: Lau HW
      – PersonEntity:
          Name:
            NameFull: Van Audenaerde J
      – PersonEntity:
          Name:
            NameFull: Lardon F
      – PersonEntity:
          Name:
            NameFull: Smits E
      – PersonEntity:
          Name:
            NameFull: Pauwels P
      – PersonEntity:
          Name:
            NameFull: Jacobs J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 03
              Text: 2023 Mar 23
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1